182 related articles for article (PubMed ID: 32443148)
1. Kinetics of Plasma HIV Rebound in the Era of Modern Antiretroviral Therapy.
Sneller MC; Huiting ED; Clarridge KE; Seamon C; Blazkova J; Justement JS; Shi V; Whitehead EJ; Schneck RF; Proschan M; Moir S; Fauci AS; Chun TW
J Infect Dis; 2020 Oct; 222(10):1655-1659. PubMed ID: 32443148
[TBL] [Abstract][Full Text] [Related]
2. Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.
Kearney MF; Wiegand A; Shao W; Coffin JM; Mellors JW; Lederman M; Gandhi RT; Keele BF; Li JZ
J Virol; 2016 Feb; 90(3):1369-76. PubMed ID: 26581989
[TBL] [Abstract][Full Text] [Related]
3. Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals.
Clarridge KE; Blazkova J; Einkauf K; Petrone M; Refsland EW; Justement JS; Shi V; Huiting ED; Seamon CA; Lee GQ; Yu XG; Moir S; Sneller MC; Lichterfeld M; Chun TW
PLoS Pathog; 2018 Jan; 14(1):e1006792. PubMed ID: 29324842
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption.
Giron LB; Papasavvas E; Yin X; Goldman AR; Tang HY; Palmer CS; Landay AL; Li JZ; Koethe JR; Mounzer K; Kostman JR; Liu Q; Montaner LJ; Abdel-Mohsen M
mBio; 2021 Feb; 12(1):. PubMed ID: 33622719
[TBL] [Abstract][Full Text] [Related]
5. Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies.
Li JZ; Aga E; Bosch RJ; Pilkinton M; Kroon E; MacLaren L; Keefer M; Fox L; Barr L; Acosta E; Ananworanich J; Coombs R; Mellors JW; Landay AL; Macatangay B; Deeks S; Gandhi RT; Smith DM
Clin Infect Dis; 2022 Mar; 74(5):865-870. PubMed ID: 34117753
[TBL] [Abstract][Full Text] [Related]
6. Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus.
Hellmuth J; Muccini C; Colby DJ; Kroon E; de Souza M; Crowell TA; Chan P; Sacdalan C; Intasan J; Benjapornpong K; Tipsuk S; Puttamaswin S; Chomchey N; Valcour V; Sarnecki M; Tomaka F; Krebs SJ; Slike BM; Jagodzinski LL; Dumrongpisutikul N; Sailasuta N; Samboju V; Michael NL; Robb ML; Vasan S; Ananworanich J; Phanuphak P; Phanuphak N; Paul R; Spudich S
Clin Infect Dis; 2021 Oct; 73(7):e1885-e1892. PubMed ID: 32916708
[TBL] [Abstract][Full Text] [Related]
7. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption.
Li JZ; Etemad B; Ahmed H; Aga E; Bosch RJ; Mellors JW; Kuritzkes DR; Lederman MM; Para M; Gandhi RT
AIDS; 2016 Jan; 30(3):343-53. PubMed ID: 26588174
[TBL] [Abstract][Full Text] [Related]
8. Virologic and Immunologic Features of Simian Immunodeficiency Virus Control Post-ART Interruption in Rhesus Macaques.
Strongin Z; Micci L; Fromentin R; Harper J; McBrien J; Ryan E; Shenvi N; Easley K; Chomont N; Silvestri G; Paiardini M
J Virol; 2020 Jul; 94(14):. PubMed ID: 32350073
[TBL] [Abstract][Full Text] [Related]
9. Impact of analytical treatment interruption on the central nervous system in a simian-HIV model.
Hsu DC; Silsorn D; Inthawong D; Kuncharin Y; Sopanaporn J; Im-Erbsin R; Chumpolkulwong K; O'connell RJ; Michael NL; Ege CA; Vasan S
AIDS; 2019 Dec; 33 Suppl 2():S189-S196. PubMed ID: 31789818
[TBL] [Abstract][Full Text] [Related]
10. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
[TBL] [Abstract][Full Text] [Related]
11. Impact of Treatment Interruption on HIV Reservoirs and Lymphocyte Subsets in Individuals Who Initiated Antiretroviral Therapy During the Early Phase of Infection.
Huiting ED; Gittens K; Justement JS; Shi V; Blazkova J; Benko E; Kovacs C; Wender PA; Moir S; Sneller MC; Fauci AS; Chun TW
J Infect Dis; 2019 Jun; 220(2):270-274. PubMed ID: 30840763
[TBL] [Abstract][Full Text] [Related]
12. HIV RNA Rebound in Seminal Plasma after Antiretroviral Treatment Interruption.
Gianella S; Chaillon A; Chun TW; Sneller MC; Ignacio C; Vargas-Meneses MV; Caballero G; Ellis RJ; Kovacs C; Benko E; Huibner S; Kaul R
J Virol; 2020 Jul; 94(15):. PubMed ID: 32434884
[TBL] [Abstract][Full Text] [Related]
13. Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations.
Zheng L; Tierney C; Bosch RJ
Curr HIV/AIDS Rep; 2021 Oct; 18(5):475-482. PubMed ID: 34213731
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: Toll-like Receptor 9-1635A/G Polymorphism Is Associated With HIV-1 Rebound After Four Weeks of Interruption of Antiretroviral Therapy.
Vallejo A; Molina-Pinelo S; de Felipe B; Abad-Fernández M; González-Escribano MF; Leal M; Soriano-Sarabia N
J Acquir Immune Defic Syndr; 2020 Oct; 85(2):252-256. PubMed ID: 32658127
[TBL] [Abstract][Full Text] [Related]
15. Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption.
Wang CY; Wong WW; Tsai HC; Chen YH; Kuo BS; Lynn S; Blazkova J; Clarridge KE; Su HW; Lin CY; Tseng FC; Lai A; Yang FH; Lin CH; Tseng W; Lin HY; Finstad CL; Wong-Staal F; Hanson CV; Chun TW; Liao MJ
N Engl J Med; 2019 Apr; 380(16):1535-1545. PubMed ID: 30995373
[TBL] [Abstract][Full Text] [Related]
16. Circulating CD30+CD4+ T Cells Increase Before Human Immunodeficiency Virus Rebound After Analytical Antiretroviral Treatment Interruption.
Prator CA; Thanh C; Kumar S; Pan T; Peluso MJ; Bosch R; Jones N; Milush JM; Bakkour S; Stone M; Busch MP; Deeks SG; Hunt PW; Henrich TJ
J Infect Dis; 2020 Mar; 221(7):1146-1155. PubMed ID: 31677350
[TBL] [Abstract][Full Text] [Related]
17. Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity.
McGuinty M; Angel JB; Cooper CL; Cowan J; MacPherson PA; Kumar A; Murthy S; Sy R; Dennehy M; Tremblay N; Byrareddy SN; Cameron DW
BMJ Open; 2020 Oct; 10(10):e041359. PubMed ID: 33033101
[TBL] [Abstract][Full Text] [Related]
18. Acute HIV-1 infection viremia associate with rebound upon treatment interruption.
Mdluli T; Li Y; Pinyakorn S; Reeves DB; Cardozo-Ojeda EF; Yates A; Intasan J; Tipsuk S; Phanuphak N; Sacdalan C; Colby DJ; Kroon E; Crowell TA; Thomas R; Robb ML; Ananworanich J; de Souza M; Phanuphak P; Stieh DJ; Tomaka FL; Trautmann L; Ake JA; Hsu DC; Francisco LV; Vasan S; Rolland M
Med; 2022 Sep; 3(9):622-635.e3. PubMed ID: 35870446
[TBL] [Abstract][Full Text] [Related]
19. Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.
Palich R; Ghosn J; Chaillon A; Boilet V; Nere ML; Chaix ML; Delobel P; Molina JM; Lucht F; Bouchaud O; Rieux V; Thiebaut R; Levy Y; Delaugerre C; Lelievre JD;
AIDS; 2019 Feb; 33(2):279-284. PubMed ID: 30325777
[TBL] [Abstract][Full Text] [Related]
20. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
Cummins NW; Rizza S; Litzow MR; Hua S; Lee GQ; Einkauf K; Chun TW; Rhame F; Baker JV; Busch MP; Chomont N; Dean PG; Fromentin R; Haase AT; Hampton D; Keating SM; Lada SM; Lee TH; Natesampillai S; Richman DD; Schacker TW; Wietgrefe S; Yu XG; Yao JD; Zeuli J; Lichterfeld M; Badley AD
PLoS Med; 2017 Nov; 14(11):e1002461. PubMed ID: 29182633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
